Replies to post #23551 on Nascent Pharma Holdings Inc (NASC)

[skyhawk66]

Nice, clearly one can see CANB outperform the competition.

[sleekscape]

Pure CBD Oil vs Full Spectrum CBD — 3 Month Chart

CANB outperformed Full Spectrum CBD Oil (CVSI/ELLXF/CWBHF) in November and December 2019, but in January 2020 it has really started to pull away

The market likes Pure CBD Oil and CANB:

https://stockcharts.com/freecharts/perf.php?CANB,CVSI,ELLXF,CWBHF&n=62&O=011000

https://stockcharts.com/freecharts/perf.php?CANB,CVSI,ELLXF,CWBHF&n=62&O=111000


Broad Spectrum CBD has performed even worse

Here’s Pure CBD Oil vs Full Spectrum AND Broad Spectrum CBD (EDXC, YCBD):

https://stockcharts.com/freecharts/perf.php?CANB,CVSI,ELLXF,CWBHF,EDXC,YCBD&n=62&O=011000

https://stockcharts.com/freecharts/perf.php?CANB,CVSI,ELLXF,CWBHF,EDXC,YCBD&n=62&O=111000


Here are the % gains over the past 3 months for the CBD Oil sector as a whole by formulation:


Pure CBD — CBD Only

CANB +18%


Full Spectrum CBD — CBD + THC + CBG/CBN/CBC

CWBHF -35%

ELLXF -39%

CVSI -41%


Broad Spectrum CBD — CBD + CBG/CBN/CBC

EDXC -54%

YCBD -73%


Here’s everything lined up by % gain:

CANB +18%

CWBHF -35%

ELLXF -39%

CVSI -41%

EDXC -54%

YCBD -73%


Here’s the Pure CBD Theory posted in July 2019 and the supporting evidence that came in between July-Dec 2019:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152838258


Sleek